Hameetman Liesbeth, Bovée Judith Vmg, Taminiau Antonie Hm, Kroon Herman M, Hogendoorn Pancras Cw
Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands.
Hered Cancer Clin Pract. 2004 Nov 15;2(4):161-73. doi: 10.1186/1897-4287-2-4-161.
Multiple Osteochondromas is an autosomal dominant disorder characterised by the presence of multiple osteochondromas and a variety of orthopaedic deformities. Two genes causative of Multiple Osteochondromas, Exostosin-1 (EXT1) and Exostosin-2 (EXT2), have been identified, which act as tumour suppressor genes. Osteochondroma can progress towards its malignant counterpart, secondary peripheral chondrosarcoma and therefore adequate follow-up of Multiple Osteochondroma patients is important in order to detect malignant transformation early.This review summarizes the considerable recent basic scientific and clinical understanding resulting in a multi-step genetic model for peripheral cartilaginous tumorigenesis. This enabled us to suggest guidelines for clinical management of Multiple Osteochondroma patients. When a patient is suspected to have Multiple Osteochondroma, the radiologic documentation, histology and patient history have to be carefully reviewed, preferably by experts and if indicated for Multiple Osteochondromas, peripheral blood of the patient can be screened for germline mutations in either EXT1 or EXT2. After the Multiple Osteochondroma diagnosis is established and all tumours are identified, a regular follow-up including plain radiographs and base-line bone scan are recommended.
多发性骨软骨瘤是一种常染色体显性疾病,其特征为存在多发性骨软骨瘤及多种骨科畸形。已鉴定出导致多发性骨软骨瘤的两个基因,即外生骨疣蛋白-1(EXT1)和外生骨疣蛋白-2(EXT2),它们起肿瘤抑制基因的作用。骨软骨瘤可发展为其恶性对应物,继发性外周软骨肉瘤,因此对多发性骨软骨瘤患者进行充分随访对于早期发现恶性转化很重要。本综述总结了近期关于外周软骨肿瘤发生的多步骤遗传模型的大量基础科学和临床认识。这使我们能够提出多发性骨软骨瘤患者临床管理的指南。当怀疑患者患有多发性骨软骨瘤时,必须仔细审查放射学记录、组织学和患者病史,最好由专家进行审查,如果怀疑为多发性骨软骨瘤,可对患者外周血进行EXT1或EXT2种系突变筛查。在确立多发性骨软骨瘤诊断并识别所有肿瘤后,建议进行包括X线平片和基线骨扫描在内的定期随访。